A study to Assess the Pharmacokinetics of AZD4831 when Administered Alone and in Combination with Itraconazole

Study identifier:D6580C00013

ClinicalTrials.gov identifier:NCT05236543

EudraCT identifier:2021-005727-21

CTIS identifier:N/A

Study Complete

Official Title

An Open-label, Fixed Sequence Study in Healthy Subjects to Assess the Pharmacokinetics of AZD4831 when Administered Alone and in Combination with Itraconazole

Medical condition

Healthy Volunteers

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD4831, Itraconazole

Sex

All

Actual Enrollment

21

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 18 Feb 2022
Primary Completion Date: 12 Aug 2022
Study Completion Date: 12 Aug 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Jul 2023 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL

Inclusion and exclusion criteria